தேசிய ஆரோக்கியம் ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தேசிய ஆரோக்கியம் ஆராய்ச்சி நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தேசிய ஆரோக்கியம் ஆராய்ச்சி நிறுவனம் Today - Breaking & Trending Today

Контакты помогают заключать контракты | Интервью, выступления, публикации | Официальный сайт Палаты Представителей Национального собрания Республики Беларусь

Контакты помогают заключать контракты | Интервью, выступления, публикации | Официальный сайт Палаты Представителей Национального собрания Республики Беларусь
house.gov.by - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from house.gov.by Daily Mail and Mail on Sunday newspapers.

United States , Belarus General , Russian Federation , Atlantic Ocean , National Health Research Institute , Representatives Of The National Assembly , National Assembly Of The Republic As , Viii Forum , Trip Parliamentary Assembly , Higher State Council , Nuclear Power , Contacts Are , House Of Representatives , National Assembly , Republic As Well , Upcoming Intergovernmental , Union State , Legal Basis , Russia Which Regions And The , Belarusian Road , Are The , Russia Accounts , New Cases , Beds Are , May Beds , Country As Well ,

DNA vaccine created new hope in war with Corona know about it

DNA vaccine created new hope in war with Corona know about it
jagran.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jagran.com Daily Mail and Mail on Sunday newspapers.

T Ai Pei , National Health Research Institute , Clinical Trial , டி ஐ பேய் , தேசிய ஆரோக்கியம் ஆராய்ச்சி நிறுவனம் , மருத்துவ சோதனை ,

Adimmune slides into red on rising R&D expenditure


Adimmune slides into red on rising R&D expenditure
By Kao Shih-ching / Staff reporter
Vaccine maker Adimmune Corp (國光生技) yesterday reported a net loss of NT$249 million (US$8.91 million) for last quarter, compared with a net profit of NT$1.24 billion in the fourth quarter of last year, due to rising research and development (R&D) expenses that involved a phase 1 clinical trial for its experimental vaccine against COVID-19.
That translates into a loss per share of NT$0.58, widening from minus-NT$0.05 a year earlier.
Revenue last quarter sank 98 percent year-on-year to NT$6.9 million due to a high comparison base last year, it said. ....

Adimmune Corp , Shenzhen Techdow Pharmaceutical Co , National Health Research Institute On , Kao Shih Ching , National Health Research Institute , Middle Eastern , The Taipei Times , காவ் ஷிஹ் சிங் , தேசிய ஆரோக்கியம் ஆராய்ச்சி நிறுவனம் , நடுத்தர கிழக்கு , தி தைப்பே முறை ,